2003
DOI: 10.1099/jmm.0.05091-0
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a rapid bacteriophage-based method for the detection of Mycobacterium tuberculosis in clinical samples

Abstract: Rapid, sensitive and low-cost methods are needed urgently for the detection of Mycobacterium tuberculosis in clinical samples, especially in developing countries. To this end, the clinical performance of FASTPlaqueTB TM (a bacteriophage-based method) has been studied in parallel with microscopy, standard microbiological culture and in-house IS6110-based PCR methods. A total of 64 samples, including 42 sputum samples and 22 urine samples, were tested in this study. The sensitivity, specificity and overall accur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
24
0
1

Year Published

2004
2004
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(26 citation statements)
references
References 20 publications
1
24
0
1
Order By: Relevance
“…It is unclear if the DS6A-based fluorophage is a better alternative to ⌽ 2 GFP10, considering that the performances of DS6A and ⌽ 2 GFP10 are comparable on laboratory-grown cultures of M. tuberculosis, and that DS6A, in most cases, is relatively less efficient at infecting NTM in comparison to ⌽ 2 GFP10. The second test uses the commercially available FASTPlaque tuberculosis (TB) assay (40) in which D29 phages are used to infect patient samples; extracellular phages are then neutralized, and D29 progeny phages are screened by visualizing plaque formation on lawns of fast-growing M. smegmatis. Although our DS6A fluorophage does not form plaques on lawns of M. smegmatis, these phages could be used to modify this assay and potentially reduce the time to diagnosis from days to hours.…”
Section: Discussionmentioning
confidence: 99%
“…It is unclear if the DS6A-based fluorophage is a better alternative to ⌽ 2 GFP10, considering that the performances of DS6A and ⌽ 2 GFP10 are comparable on laboratory-grown cultures of M. tuberculosis, and that DS6A, in most cases, is relatively less efficient at infecting NTM in comparison to ⌽ 2 GFP10. The second test uses the commercially available FASTPlaque tuberculosis (TB) assay (40) in which D29 phages are used to infect patient samples; extracellular phages are then neutralized, and D29 progeny phages are screened by visualizing plaque formation on lawns of fast-growing M. smegmatis. Although our DS6A fluorophage does not form plaques on lawns of M. smegmatis, these phages could be used to modify this assay and potentially reduce the time to diagnosis from days to hours.…”
Section: Discussionmentioning
confidence: 99%
“…Microscopy and culture are generally considered to be the authoritative methods for the laboratory diagnosis of TB. However, smear microscopy is limited due to low sensitivity in paucibacillary specimens (Marei et al 2003). On the other hand, culture remains the gold standard for diagnosis of mycobacterial infections, although it is time consuming and prone to contamination (McNerney 1996, Nancy et al 2000.…”
mentioning
confidence: 99%
“…The Mycobacteria Growth Indicator Tube (MGIT) (Becton Dickinson) provides rapid recovery of mycobacteria from clinical specimens (Badak et al 1996). Alternatively, the rapid detection and counting of Mycobacterium tuberculosis complexes from both respiratory and non-respiratory tract specimens may be achieved using the Biotec FASTPlaque TB™ (FPTB) assay (Biotec laboratories ltd, UK), which utilizes a phage amplification technology (Albert et al 2002, Marei et al 2003.…”
mentioning
confidence: 99%
“…The clinical effects of this assay have been evaluated in several countries, including Egypt (27), Pakistan (28), South Africa (29) and Spain (30). Kalantri et al (31) performed a meta-analysis of the detection of M. tuberculosis in clinical samples, based on phage amplification technology in 2005 by examining the literature from databases, including Medline, EMBASE (http://www.elsevier.com/online-tools/embase), Web of Science (http://wok.mimas.ac.uk/) and BIOSIS Previews (http://biosispreviews.isihost.com/).…”
Section: Tb Diagnosis and Drug Sensitivity Assessments Based On Mycobmentioning
confidence: 99%